Low‐dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency
The DOI matches its Crossref record.
Abstract
OBJECTIVE The ob gene product, leptin, is considered to be a marker of adipose tissue mass and a possible homeostatic regulator of body mass. Our objective was to examine the effect of GH replacement on adipose tissue stores and leptin in adult hypopituitarism. SUBJECTS Twenty adults, mean age 47 years (range 20–69) with proven GH deficiency were randomly allocated to either GH (up to 0.25 U/kg/week in daily doses) or placebo for 3 months before cross‐over to the opposite treatment. MEASUREMENTS Body composition was measured by dual‐energy X‐ray absorptiometry (DEXA) in the whole body, trunk and limbs. Plasma leptin was measured by radioimmunoassay at baseline and +2, +4, +8 and +12 weeks in each treatment arm. RESULTS Total body tissue fat (mean±SE) was 30.1±2.2% after GH compared with 31.9±2.2% after placebo, P<0.001 (ANOVA). There were no significant changes in BMI (kg/m 2), 29.1±1.3 after placebo vs 28.8±1.2 after GH; or waist to hip ratio (WHR), 0.91±0.01 after both placebo and GH. Baseline plasma leptin showed a significant correlation with baseline BMI, r=0.67, P<0.005 and baseline percentage total body fat, R=0.89, P<0.001. Plasma leptin (adjusted by using baseline percentage total body fat as a covariate) showed a significant linear decrease with time on GH compared with placebo (P=0.03 ANOVA). CONCLUSIONS Plasma leptin and total body fat fall promptly in response to low‐dose replacement of GH in GH‐deficient subjects. Hormone‐induced changes in leptin can occur in humans in the absence of change in body mass index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Neuroendocrine Control of Growth Hormone Secretion
Müller, E. E., Locatelli, V., & Cocchi, D. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.2.511 · Cited by 634
Human leptin: from an adipocyte hormone to an endocrine mediator
Wauters, M., Considine, R., & Van Gaal, L. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430293 · Cited by 460
Neuroendocrine Regulation and Actions of Leptin
Casanueva, F. F., & Dieguez, C. (1999) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0187 · Cited by 387
Maison, P., Griffin, S., Nicoue-Beglah, M., Haddad, N., Balkau, B., & Chanson, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030840 · Cited by 362
Scacchi, M., Pincelli, A., & Cavagnini, F. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0800807 · Cited by 316
Metadata
- Authors
- Florkowski, C. M., Collier, G. R., Zimmet, P. Z., Livesey, J. H., Espiner, E. A., & Donald, R. A.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 1996-12
- Volume
- 45
- Issue
- 6
- Pages
- 769-773
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W1988064413
- Cited by
- 102
- References
- 0
- FWCI
- 10.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Low‐dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency. https://app.cochat.ai/papers/10.1046/j.1365-2265.1996.830895.x
- The paper
- Florkowski, C. M., Collier, G. R., Zimmet, P. Z., Livesey, J. H., Espiner, E. A., & Donald, R. A. (1996). Low‐dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.1996.830895.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.